Olga Frankfurt

  • 1216 Citations
19992023
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Certifications and Licenses

Internal Medicine
Medical Oncology
Hematology

Training Experience

2002Residency, Rush University Medical Center
2005Fellowship, Northwestern University, McGaw Medical Center (Northwestern Memorial Hospital)

Education/Academic qualification

MD, University of Chicago

… → 1999

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 23 Similar Profiles
Acute Myeloid Leukemia Medicine & Life Sciences
Hematopoietic Stem Cell Transplantation Medicine & Life Sciences
Hematopoietic Stem Cells Medicine & Life Sciences
Myelodysplastic Syndromes Medicine & Life Sciences
Leukemia, Myelogenous, Chronic, BCR-ABL Positive Medicine & Life Sciences
Transplants Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Acute Promyelocytic Leukemia Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 1999 2023

Research Output 2004 2018

Blinatumomab and pancreatitis: an analysis of FAERS, EudraVigilance, and a large urban U.S. patient population data

Vakharia, P., Nardone, B., Budris, W., Hoshizaki, K., Frankfurt, O. & West, D. P., Jul 3 2018, In : Leukemia and Lymphoma. 59, 7, p. 1759-1761 3 p.

Research output: Contribution to journalEditorial

Pancreatitis
Population
blinatumomab
7 Citations

Results of a phase 1 study of quizartinib as maintenance therapy in subjects with acute myeloid leukemia in remission following allogeneic hematopoietic stem cell transplant

Sandmaier, B. M., Khaled, S., Oran, B., Gammon, G., Trone, D. & Frankfurt, O., Feb 1 2018, In : American Journal of Hematology. 93, 2, p. 222-231 10 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cells
Acute Myeloid Leukemia
Transplants
Maximum Tolerated Dose
Recurrence
2 Citations

Disease characteristics and prognosis of myelodysplastic syndrome presenting with isolated thrombocytopenia

Waisbren, J., Dinner, S. N., Altman, J. K., Frankfurt, O., Helenowski, I., Gao, J., McMahon, B. J. & Stein, B. L., Jan 1 2017, In : International Journal of Hematology. 105, 1, p. 44-51 8 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Thrombocytopenia
Thrombopoietin Receptors
Tertiary Care Centers
Cytogenetics
4 Citations
Large Granular Lymphocytic Leukemia
Human Herpesvirus 4
Lymphoma
Polycomb Repressive Complex 2
Natural Killer Cells
44 Citations

Myelodysplastic syndromes, version 2.2017: Clinical practice guidelines in oncology

Greenberg, P. L., Stone, R. M., Al-Kali, A., Barta, S. K., Bejar, R., Bennett, J. M., Carraway, H., De Castro, C. M., Deeg, H. J., DeZern, A. E., Fathi, A. T., Frankfurt, O., Gaensler, K., Garcia-Manero, G., Griffiths, E. A., Head, D., Horsfall, R., Johnson, R. A., Juckett, M., Klimek, V. M. & 12 othersKomrokji, R., Kujawski, L. A., Maness, L. J., O'Donnell, M. R., Pollyea, D. A., Shami, P. J., Stein, B. L., Walker, A. R., Westervelt, P., Zeidan, A., Shead, D. A. & Smith, C., Jan 1 2017, In : JNCCN Journal of the National Comprehensive Cancer Network. 15, 1, p. 60-87 28 p.

Research output: Contribution to journalReview article

Myelodysplastic Syndromes
Practice Guidelines
Therapeutics
Molecular Pathology
Cytogenetics